Physician profile
Arjun Basnet
NPI 1730789959
$2,727.21
in general payments reported to CMS, 2019-2025
14 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $211 · 2024: $1,296 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456 · Education: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,455.69 |
| Education | $271.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $842.76 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $605.61 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $418.27 | 2024-2025 | Ensite, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $295.88 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals Lp | $227.03 | 2023-2025 | Farxiga, Lokelma, Brilinta |
| Novartis Pharmaceuticals Corporation | $85.53 | 2025 | |
| Janssen Pharmaceuticals, INC | $59.67 | 2024 | Xarelto |
| Medtronic, INC. | $51.76 | 2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $29.32 | 2024 | |
| Mannkind Corporation | $27.97 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $26.63 | 2024 | Arcalyst |
| Csl Behring | $21.48 | 2023 | Kcentra |
| Edwards Lifesciences Corporation | $21.06 | 2023 | Sapien 3 Ultra Resilia |
| Inspire Medical Systems, INC. | $14.24 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Basnet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.